Zytiga 250 MG Oral Tablet

RxCUI: 1100079
RxNorm name: Zytiga 250 MG Oral Tablet
Display name: Zytiga 250 MG Oral Tablet
Full name: Zytiga 250 MG Oral Tablet
Term type: SY
Status: DailyMed mapping
Updated: 2026-06-04 23:38:57

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Zytiga	ABIRATERONE ACETATE	Janssen Biotech, Inc.	4e338e89-3cf2-48eb-b6e2-a06c608c6513	2025-03-28	Warnings, Adverse reactions	Exact identifier rxcui: 1100079

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
4e338e89-3cf2-48eb-b6e2-a06c608c6513	Zytiga 250 MG Oral Tablet	SY	40	These highlights do not include all the information needed to use ZYTIGA safely and effectively. See full prescribing information for ZYTIGA. ZYTIGA ® (abiraterone acetate) tablets, for oral use Initial U.S. Approval: 2011	20250328
4e338e89-3cf2-48eb-b6e2-a06c608c6513	abiraterone acetate 250 MG Oral Tablet [Zytiga]	SBD	40	These highlights do not include all the information needed to use ZYTIGA safely and effectively. See full prescribing information for ZYTIGA. ZYTIGA ® (abiraterone acetate) tablets, for oral use Initial U.S. Approval: 2011	20250328
4e338e89-3cf2-48eb-b6e2-a06c608c6513	Zytiga 250 MG Oral Tablet	PSN	40	These highlights do not include all the information needed to use ZYTIGA safely and effectively. See full prescribing information for ZYTIGA. ZYTIGA ® (abiraterone acetate) tablets, for oral use Initial U.S. Approval: 2011	20250328